Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,299 | 1,042 | 98.8% |
| Education | $217.63 | 11 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,336 | 119 | $0 (2024) |
| Lilly USA, LLC | $2,050 | 126 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,770 | 97 | $0 (2024) |
| Novo Nordisk Inc | $1,669 | 172 | $0 (2024) |
| ABBVIE INC. | $1,280 | 79 | $0 (2024) |
| Amgen Inc. | $1,039 | 62 | $0 (2023) |
| PFIZER INC. | $829.26 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $674.58 | 36 | $0 (2024) |
| Amarin Pharma Inc. | $621.42 | 49 | $0 (2021) |
| GlaxoSmithKline, LLC. | $512.26 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,954 | 101 | Lilly USA, LLC ($309.41) |
| 2023 | $2,594 | 135 | Lilly USA, LLC ($324.64) |
| 2022 | $2,069 | 123 | Novo Nordisk Inc ($298.53) |
| 2021 | $2,435 | 150 | AbbVie Inc. ($472.58) |
| 2020 | $2,182 | 135 | AstraZeneca Pharmaceuticals LP ($346.95) |
| 2019 | $2,438 | 140 | AstraZeneca Pharmaceuticals LP ($585.56) |
| 2018 | $1,947 | 134 | AstraZeneca Pharmaceuticals LP ($440.53) |
| 2017 | $1,897 | 135 | AstraZeneca Pharmaceuticals LP ($298.02) |
All Payment Transactions
1,053 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: VACCINE | ||||||
| 11/15/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Biological | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: VACCINE | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,140 | 1,757 | $156,833 | $90,471 |
| 2022 | 12 | 1,032 | 1,509 | $139,494 | $81,130 |
| 2021 | 17 | 964 | 1,420 | $124,005 | $75,257 |
| 2020 | 19 | 979 | 1,571 | $121,062 | $62,412 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 462 | $48,510 | $31,293 | 64.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $39,300 | $18,387 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 158 | $24,806 | $12,669 | 51.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 152 | 152 | $18,240 | $12,044 | 66.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 155 | $10,075 | $6,230 | 61.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 134 | 134 | $4,020 | $2,768 | 68.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 163 | 339 | $2,750 | $2,400 | 87.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $2,358 | $1,972 | 83.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 29 | 29 | $1,450 | $919.88 | 63.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 68 | $2,584 | $766.99 | 29.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 30 | 30 | $1,260 | $613.41 | 48.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 40 | $1,480 | $407.73 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 273 | $42,861 | $25,084 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 291 | $30,555 | $19,093 | 62.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $33,000 | $15,875 | 48.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 90 | 90 | $10,800 | $7,552 | 69.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 82 | $5,310 | $3,642 | 68.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 79 | $2,991 | $2,605 | 87.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 120 | 120 | $3,600 | $2,499 | 69.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 69 | 70 | $3,500 | $2,087 | 59.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,856 | $1,092 | 38.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 151 | 317 | $1,590 | $939.18 | 59.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 38 | $1,432 | $382.91 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 26 | 27 | $999.00 | $278.49 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 251 | $39,407 | $22,997 | 58.4% |
About Dr. Joseph Yi, MD
Dr. Joseph Yi, MD is a Family Medicine healthcare provider based in Buena Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861565285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Yi, MD has received a total of $17,517 in payments from pharmaceutical and medical device companies, with $1,954 received in 2024. These payments were reported across 1,053 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($17,299).
As a Medicare-enrolled provider, Yi has provided services to 4,115 Medicare beneficiaries, totaling 6,257 services with total Medicare billing of $309,270. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Buena Park, CA
- Active Since 11/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861565285
Products in Payments
- FARXIGA (Drug) $1,791
- JARDIANCE (Drug) $1,554
- Ozempic (Drug) $814.82
- MOUNJARO (Drug) $640.33
- EVENITY (Biological) $631.24
- Vascepa (Drug) $621.42
- LINZESS (Drug) $518.94
- TRULICITY (Drug) $506.64
- Rybelsus (Drug) $373.38
- ENTRESTO (Drug) $350.93
- TRADJENTA (Drug) $336.38
- Creon (Drug) $333.47
- BREZTRI (Drug) $289.64
- Kerendia (Drug) $273.06
- Tymlos (Biological) $262.93
- EMGALITY (Drug) $253.34
- Korlym (Drug) $241.30
- MYRBETRIQ (Drug) $240.79
- TRELEGY ELLIPTA (Drug) $229.15
- Amitiza (Drug) $224.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Buena Park
Mercedes Samson, M.d, M.D
Family Medicine — Payments: $26,453
Dr. Martin Ahn, M.d, M.D
Family Medicine — Payments: $11,644
Dr. Steven Smith, M.d, M.D
Family Medicine — Payments: $510.09
Mirna Chambi, Md, MD
Family Medicine — Payments: $229.80
Mr. Vey Chen, D.o, D.O
Family Medicine — Payments: $114.43
Dr. Inil Lin, M.d, M.D
Family Medicine — Payments: $59.65